2012 Movember Clinician Scientist










Prostate Cancer Canada would like to recognize the Movember Foundation as a key funder of this program.
Prostate Cancer Canada is pleased to announce the awarding of 2 Movember Clinician Scientist Awards. 

In order to decide which research projects should receive funding, each application is thoroughly reviewed by at least two cancer experts. These experts make recommendations to PCC regarding which research projects to fund. This process is called 'peer review'. The peer review process ensures that only the most meritorious research is supported. This year's successful research projects explore many different areas of prostate cancer including novel treatment therapies and the development of new tools to help better predict disease progression. 


Movember Clinician Scientist Awards

Investigator Host Institution Project Title Total Award   Award Period        
Peter Black University of British Columbia Circulating tumour cells in prostate cancer: the metastatic window $300,000  July 1, 2012- June 30, 2014
Girish Kulkarni Princess Margaret Hospital        Biopsy avoidance in patients at risk for prostate cancer and in patients with low risk prostate cancer: developing tools for personalized medicine $300,000 July 1, 2012 -
June 30, 2014













Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
‘Doing it for Dads’ this Father’s Day: Albertans unite for prostate cancer research

Building Trades of Alberta and multiple community fundraisers have raised $330,000 and counting  Calgary – May 27th, 2015:  In the lead-up to Father’s Day, Prostate Cancer Canada (PCC) is excited to announce that Albertans have demonstrated significant leadership by banding together to raise over $330,000 and counting in important research dollars and awareness for prostate cancer, the most common cancer to affect men. More

Groundbreaking Research Moves One Step Closer to Personalizing Prostate Cancer Treatment

Movember Foundation, Prostate Cancer Canada and the Ontario Institute for Cancer Research funded research breakthrough published in Nature Genetics   TORONTO, ON (May 25, 2015) The results of groundbreaking genetics research in Canada, funded by the Movember Foundation, the Ontario Institute for Cancer Research (OICR) and Prostate Cancer Canada, has identified a unique sub-type of prostate cancer that will help clinicians develop more personalized treatments for their patients, ensure that fewer men undergo unnecessary treatments and improve their chances of survival. More


Click here for news archive